Skip to site menu Skip to page content

JDRF, Clinton Foundation to tackle Type 1 Diabetes in India

The initiative involves supporting public health programmes, grassroots initiatives, and clinician networks.

December 13 2023

India-based non-profit organisation focused on type 1 diabetes (T1D) research and advocacy JDRF International is collaborating with community partners, clinical organisations, and the William J. Clinton Foundation to enhance T1D care in the country.

The initiative involves supporting public health programmes, grassroots initiatives, and clinician networks to create a comprehensive strategy addressing T1D.

India has the world's highest ‘missing’ prevalence of T1D globally, as per the T1D Index.

This partnership aims to improve screening, diagnosis, and management of T1D, supported by the Indian government's comprehensive programmes.

The developments in diabetes care are backed by The Impatient Network, a coalition of diabetes advocates, is involved in providing education, support services, and resources.

This collaboration focuses on establishing best practices in T1D care by integrating clinical expertise with community insights.

The effort is supported by partnerships with institutions including the Research Society for the Study of Diabetes in India, the Indian Society for Paediatric and Adolescent Endocrinology, and the Endocrine Society of India.

In addition, Eli Lilly and Company is contributing through its Lilly 30×30 initiative to improve healthcare access in resource-limited settings.

William J. Clinton Foundation managing director Harkesh Dabas said: “At William J. Clinton Foundation, we are deeply committed to partnering with and supporting public health programmes for comprehensive management of type 1 diabetes in select states of India.

“Our approach is that of collaboration and facilitation and our partnership with JDRF is designed to complement and enhance government-led diabetes care programmes.

“We aim to bolster the implementation and scaling of these important initiatives.

“Our involvement underscores a public healthcare owned and led initiative and collaborative spirit, ensuring that the strides made in type 1 diabetes care are both impactful and sustainable, and reach every individual in need across the country.”

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close